General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Veralox(MODEST), Artivion(MODEST), Bristol Myers Squibb(MODEST), Novostia(MODEST), Curis(MODEST) RESEARCH/RESEARCH GRANTS: CSL Behring (SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Artivion(SIGNIFICANT), Ferring Pharmaceuticals(SIGNIFICANT), Bristol Myers Squibb(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Boehringer Ingelheim Pharmaceuticals, Inc(MODEST)

View Full Disclosure